risedronic acid has been researched along with Fibrocartilaginous Dysplasia of Bone in 1 studies
Risedronic Acid: A pyridine and diphosphonic acid derivative that acts as a CALCIUM CHANNEL BLOCKER and inhibits BONE RESORPTION.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chapurlat, R | 1 |
1 other study available for risedronic acid and Fibrocartilaginous Dysplasia of Bone
| Article | Year |
|---|---|
Current pharmacological treatment for fibrous dysplasia and perspectives for the future.
Topics: Calcium Channel Blockers; Diphosphonates; Etidronic Acid; Fibrous Dysplasia of Bone; Humans; Randomi | 2005 |